posted on 2022-06-10, 17:34authored byVamshikrishna
Reddy Sammeta, John D. Norris, Sandeep Artham, Chad D. Torrice, Jovita Byemerwa, Carstyn Joiner, Sean W. Fanning, Donald P. McDonnell, Timothy M. Willson
Despite continued interest in the
development of nonsteroidal estrogens
and antiestrogens, there are only a few chemotypes of estrogen receptor
ligands. Using targeted screening in a ligand sensing assay, we identified
a phenolic thieno[2,3-d]pyrimidine with affinity
for estrogen receptor α. An efficient three-step synthesis of
the heterocyclic core and structure-guided optimization of the substituents
resulted in a series of potent nonsteroidal estrogens. The chemical
tractability of the thieno[2,3-d]pyrimidine chemotype
will support the design of new estrogen receptor ligands as therapeutic
hormones and antihormones.